633339-34-1Relevant articles and documents
Vesicant treatment with phenyl-thiophene type vitamin d receptor modulators
-
Page/Page column 92, (2010/11/08)
The present invention relates to a method of treating or preventing damage to human skin cells by chemical vesicants by administering a non-secosteroidal, phenylthiophene compound with vitamin D receptor (VDR) modulating activity.
PHENYL-THIOPHENE TYPE VITAMIN D RECEPTOR MODULATORS
-
Page 245-246, (2008/06/13)
The present invention relates to novel, non-secosteroidal, phenyl-thiophene compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1α,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and p